BCAA 211 amino acids
High-quality Vegan BCAA supplement from Finland
BCAA 211 is a top-quality, fresh, green apple-flavored amino acid mix that contains all three branched-chain amino acids in an optimal ratio of 2:1:1. Sweetened with stevia.
Usage
Mix one measuring spoon (about 10 g) into the liquid in a shaker. The recommended dose should not be exceeded. This product is a Dietary supplement.
Formula
Daily dose includes
Branched chain amino acids BCAA 7000 mg (of which L-leucine 3500 mg, L-valine 1750 mg and L-isoleucine 1750 mg.
Ingredients
Amino acids (L-leucine, L-valine, L-isoleucine), natural apple flavoring, acid (malic acid), emulsifier (lecithin from sunflower oil), sweetener (steviol glycosides).
Warning/Allergy
Lactose-free, gluten-free, yeast-free and soy-free. Vegan.
Sweetened with stevia.
People with diabetes or preexisting mental health disorders may need to exercise caution when taking BCAA supplements.
Pregnant or lactating women should generally avoid BCAA supplements because their safety has not been established in these populations.
Please check the list of ingredients and the instructions for use on the package before using the product. A nutritional supplement does not replace a varied and balanced diet or a healthy lifestyle. Do not exceed the recommended dosage.
Storage
Not in the reach of children.
More Information
Branched-chain amino acids (BCAA) benefits
- Bring on muscle growth
- Reduces muscular pain
- Experience less exercise tiredness
- Prevent muscular wasting
- Increase your appetite if you are malnourished or have cancer
- Reduce symptoms of tardive dyskinesia
- Reduces symptoms of cirrhosis-induced hepatic encephalopathy
- Prevent persons with cirrhosis from developing liver cancer
BCAA supplements may provide higher muscle-protective effects if taken daily at 91 mg per pound (200 mg per kg) of body weight, including nonexercise days.
It may also be helpful to divide your daily BCAA supplement intake into two or more doses.
BCAAs are also used to treat impaired brain function in persons with advanced liver disease, as well as a movement condition commonly caused by antipsychotic medicines.